A groundbreaking development in fertility treatment has emerged, and it's set to revolutionize the way we approach IVF. The future of fertility is here, and it's tiny!
A university spin-off, IVFmicro, has secured a substantial £3.5 million investment to create a revolutionary liquid circuit for fertility clinics. This innovative approach aims to enhance the success and accessibility of IVF, offering hope to countless individuals and couples facing fertility challenges.
Early trials have shown remarkable results, with the potential to improve embryo quality and quantity by an impressive 15%. The secret lies in a "microfluidic" device, a miniature chip that precisely manipulates and mixes minuscule amounts of liquid through microscopic channels. This technology mimics the natural environment of the body, providing embryos with an optimal growth environment.
But here's where it gets controversial... IVFmicro's approach challenges the traditional "petri dish" method, suggesting that the natural-like environment of the microfluidic device could significantly increase pregnancy chances. By improving the number of viable embryos and the likelihood of successful implantation, patients may require fewer treatment cycles, reducing both the physical and emotional toll of fertility treatment.
IVFmicro has gained support from influential investors, including Northern Gritstone, chaired by Lord O'Neill of Gatley. This investment highlights the potential impact of this innovation on society's approach to infertility.
The story behind IVFmicro is an inspiring one. Helen Picton, the scientific director, and Virginia Pensabene, the CEO, joined forces in 2017 at Leeds University. Their expertise in reproduction and microfluidics, respectively, led to a potential scientific breakthrough.
Helen Picton, a renowned professor, has contributed significantly to reproductive science, including helping the first woman conceive from a frozen ovary. Virginia Pensabene, a biomedical engineer, brings expertise in microfluidics, having previously used the technology for drug testing.
Virginia Pensabene shares, "We've demonstrated that our method supports embryo development far better than standard methods. Usually, the pool of embryos is limited, and many don't develop well enough for successful implantation. With our technology, we can improve the quality and quantity of embryos, increasing the chances of a successful pregnancy."
The scientists have conducted experiments using large animal embryos, similar to human embryos, with promising results. In sheep, the development rate doubled, and the pregnancy rate increased, offering a glimpse into the potential of this technology.
Northern Gritstone, along with Innovate UK's Investor Partnerships programme, leads the investment in IVFmicro. Duncan Johnson, CEO of Northern Gritstone, praises the innovation, highlighting its potential to tackle infertility while combining scientific excellence with a clear commercial vision.
This development raises intriguing questions. Could this technology be the key to unlocking successful fertility treatments for many? What impact might it have on the emotional journey of those facing infertility? Share your thoughts and join the discussion in the comments!
